Covid-19 jab pro­duc­tion has stopped at J&J's vac­cine birth­place

A J&J man­u­fac­tur­ing site in Lei­den, Nether­lands has halt­ed its pro­duc­tion of Covid-19 vac­cines, in fa­vor of mak­ing an­oth­er vac­cine that The New York Times says is more prof­itable.

The halt is not per­ma­nent, the com­pa­ny says, and pro­duc­tion is ex­pect­ed to turn back on in a few months. There is a stock­pile of dos­es, and a com­pa­ny spokesman said in an email that there are mil­lions of dos­es in in­ven­to­ry and that the com­pa­ny is “work­ing day and night” to fight the pan­dem­ic. J&J did not dis­close what the oth­er vac­cine be­ing man­u­fac­tured is, just re­it­er­at­ing in an email that it man­ages pro­duc­tion plan­ning ac­cord­ing­ly and is “cur­rent­ly sup­ply­ing from our ex­ten­sive glob­al net­work based on the de­mand for our vac­cine and the needs of our pa­tients and cus­tomers.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER